These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis. Yin Y, Wu X, Shan G, Zhang X. Lupus; 2012 Sep; 21(10):1088-97. PubMed ID: 22777943 [Abstract] [Full Text] [Related]
43. Negative anti-C1q antibody titers may influence therapeutic decisions and reduce the number of renal biopsies in systemic lupus erythematosus. Moura CG, Mangueira CL, Cruz LA, Cruz CM. Nephron Clin Pract; 2011 Sep; 118(4):c355-60. PubMed ID: 21325866 [Abstract] [Full Text] [Related]
44. Association of anti-nuclesome and anti C1q antibodies with lupus nephritis in an Egyptian cohort of patients with systemic lupus erythematosus. Metwally IM, Eesa NN, Yacoub MH, Elsman RM. Adv Rheumatol; 2019 Mar 04; 59(1):10. PubMed ID: 30832710 [Abstract] [Full Text] [Related]
45. Urine S100 proteins as potential biomarkers of lupus nephritis activity. Turnier JL, Fall N, Thornton S, Witte D, Bennett MR, Appenzeller S, Klein-Gitelman MS, Grom AA, Brunner HI. Arthritis Res Ther; 2017 Oct 24; 19(1):242. PubMed ID: 29065913 [Abstract] [Full Text] [Related]
46. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases. Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K. Scand J Rheumatol; 2007 Oct 24; 36(4):291-8. PubMed ID: 17763207 [Abstract] [Full Text] [Related]
47. Anti-C1q antibodies: a biomarker for diagnosis and management of lupus nephritis. A narrative review. Calatroni M, Moroni G, Conte E, Stella M, Reggiani F, Ponticelli C. Front Immunol; 2024 Oct 24; 15():1410032. PubMed ID: 38938561 [Abstract] [Full Text] [Related]
48. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q. Mok CC, Birmingham DJ, Ho LY, Hebert LA, Song H, Rovin BH. Lupus; 2012 Jan 24; 21(1):36-42. PubMed ID: 21993384 [Abstract] [Full Text] [Related]
49. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients. Katsumata Y, Miyake K, Kawaguchi Y, Okamoto Y, Kawamoto M, Gono T, Baba S, Hara M, Yamanaka H. Arthritis Rheum; 2011 Aug 24; 63(8):2436-44. PubMed ID: 21506094 [Abstract] [Full Text] [Related]
50. Antibodies against C1q Are a Valuable Serological Marker for Identification of Systemic Lupus Erythematosus Patients with Active Lupus Nephritis. Chi S, Yu Y, Shi J, Zhang Y, Yang J, Yang L, Liu X. Dis Markers; 2015 Aug 24; 2015():450351. PubMed ID: 26549923 [Abstract] [Full Text] [Related]
51. [Correlation of anti-C1q antibodies with active systemic lupus erythematosus and lupus nephritis in children]. Li YZ, Yang JR, Zhang YD, Cao Y, Li XY, Shuai LJ, Wang Y, Shen T, Wu XC. Zhongguo Dang Dai Er Ke Za Zhi; 2024 Aug 15; 26(8):835-839. PubMed ID: 39148388 [Abstract] [Full Text] [Related]
52. A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in Indian systemic lupus erythematosus patients. Pradhan V, Mahant G, Rajadhyaksha A, Surve P, Rajendran V, Patwardhan M, Nadkarni A, Dighe S, Ghosh K. Rheumatol Int; 2013 May 15; 33(5):1193-9. PubMed ID: 22971892 [Abstract] [Full Text] [Related]
53. The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy. Moroni G, Quaglini S, Radice A, Trezzi B, Raffiotta F, Messa P, Sinico RA. J Immunol Res; 2015 May 15; 2015():106904. PubMed ID: 25815344 [Abstract] [Full Text] [Related]
54. Serum level of proximal renal tubular epithelial cell-binding immunoglobulin G in patients with lupus nephritis. Yap DY, Yung S, Zhang Q, Tang C, Chan TM. Lupus; 2016 Jan 15; 25(1):46-53. PubMed ID: 26251400 [Abstract] [Full Text] [Related]
55. Correlation between serum anti-C1q antibody levels and renal pathological characteristics and prognostic significance of anti-C1q antibody in lupus nephritis. Cai X, Yang X, Lian F, Lin X, Liang M, Li J, Chen X, Liang L, Qin S, Fu J. J Rheumatol; 2010 Apr 15; 37(4):759-65. PubMed ID: 20194446 [Abstract] [Full Text] [Related]
56. A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone. Grootscholten C, Dieker JW, McGrath FD, Roos A, Derksen RH, van der Vlag J, Daha MR, Berden JH. Ann Rheum Dis; 2007 May 15; 66(5):693-6. PubMed ID: 17135217 [Abstract] [Full Text] [Related]
57. C1q rs292001 polymorphism and C1q antibodies in juvenile lupus and their relation to lupus nephritis. Mosaad YM, Hammad A, Fawzy Z, El-Refaaey A, Tawhid Z, Hammad EM, Youssef LF, ElAttar EA, Radwan DF, Fawzy IM. Clin Exp Immunol; 2015 Oct 15; 182(1):23-34. PubMed ID: 26095468 [Abstract] [Full Text] [Related]
58. Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity. Shang X, Ren L, Sun G, Yu T, Yao Y, Wang L, Liu F, Zhang L, He X, Liu M. Immun Inflamm Dis; 2021 Jun 15; 9(2):407-418. PubMed ID: 33470559 [Abstract] [Full Text] [Related]
59. Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare. Birmingham DJ, Bitter JE, Ndukwe EG, Dials S, Gullo TR, Conroy S, Nagaraja HN, Rovin BH, Hebert LA. Clin J Am Soc Nephrol; 2016 Jan 07; 11(1):47-53. PubMed ID: 26700439 [Abstract] [Full Text] [Related]
60. Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosus. Haddon DJ, Diep VK, Price JV, Limb C, Utz PJ, Balboni I. Arthritis Res Ther; 2015 Jun 17; 17(1):162. PubMed ID: 26081107 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]